INTERLEUKIN-1 RECEPTOR ANTAGONIST EXPRESSION IN EPITHELIAL-CELLS OF HUMAN ENDOMETRIUM

被引:12
作者
FUKUDA, M [1 ]
AZUMA, C [1 ]
KANAI, T [1 ]
KOYAMA, M [1 ]
KIMURA, T [1 ]
SAJI, F [1 ]
机构
[1] OSAKA UNIV,SCH MED,DEPT OBSTET & GYNECOL,OSAKA 553,JAPAN
关键词
INTERLEUKIN-1 RECEPTOR ANTAGONIST; INTERLEUKIN-1; ENDOMETRIUM;
D O I
10.1016/0020-7292(95)02366-K
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To examine the expression of interleukin-1 (IL-1) and IL-1 receptor antagonist (IL-1ra) in the human endometrium in the follicular and luteal phases. Methods: The concentrations of IL-1 alpha and IL-1 beta in the culture supernatants of endometrial cells were determined by enzyme-linked immunosorbent assay. Transcription of the IL-1ra gene in the endometrium was investigated by reverse polymerase chain reaction (PCR). Human endometrium was immunohistochemically stained using a monoclonal antibody specific to IL-1ra. Results: The concentrations of IL-1 alpha and IL-1 beta in the culture supernatants were II and 55 pg/ml, respectively, in the follicular phase, and 10 and 40 pg/ml, respectively, in the luteal phase. The concentration of IL-1ra was 465 pg/ml in the follicular phase and 1710 pg/ml in the luteal phase. Densitometric analysis of the reverse PCR products showed that the expression of IL-1ra mRNA was increased in endometrial cells in the luteal phase. Immunohistochemical staining revealed that epithelial cells were the main source of IL-1ra in human endometrium. Conclusions: Human endometrial cells produce IL-1 (mainly IL-1 beta) and IL-1ra. The level of IL-1ra production in human endometrial epithelial cells was greater in the luteal phase than in the follicular phase due to the increased transcription of the IL-1ra gene.
引用
收藏
页码:305 / 310
页数:6
相关论文
共 19 条
[1]   A RECOMBINANT HUMAN RECEPTOR ANTAGONIST TO INTERLEUKIN-1 IMPROVES SURVIVAL AFTER LETHAL ENDOTOXEMIA IN MICE [J].
ALEXANDER, HR ;
DOHERTY, GM ;
BURESH, CM ;
VENZON, DJ ;
NORTON, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :1029-1032
[2]   BIOLOGICAL PROPERTIES OF RECOMBINANT HUMAN MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
AREND, WP ;
WELGUS, HG ;
THOMPSON, RC ;
EISENBERG, SP .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) :1694-1697
[3]   CYTOKINES AND CYTOKINE INHIBITORS OR ANTAGONISTS IN RHEUMATOID-ARTHRITIS [J].
AREND, WP ;
DAYER, JM .
ARTHRITIS AND RHEUMATISM, 1990, 33 (03) :305-315
[4]   STEROID-HORMONES INDUCE MACROPHAGE COLONY-STIMULATING FACTOR (MCSF) AND MCSF RECEPTOR MESSENGER-RNAS IN THE HUMAN ENDOMETRIUM [J].
AZUMA, C ;
SAJI, F ;
KIMURA, T ;
TOKUGAWA, Y ;
TAKEMURA, M ;
SAMEJIMA, Y ;
TANIZAWA, O .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1990, 5 (02) :103-108
[5]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[6]   THE CELL-SURFACE RECEPTORS FOR INTERLEUKIN-1-ALPHA AND INTERLEUKIN-1-BETA ARE IDENTICAL [J].
DOWER, SK ;
KRONHEIM, SR ;
HOPP, TP ;
CANTRELL, M ;
DEELEY, M ;
GILLIS, S ;
HENNEY, CS ;
URDAL, DL .
NATURE, 1986, 324 (6094) :266-268
[7]   PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION FROM COMPLEMENTARY-DNA OF A HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
EISENBERG, SP ;
EVANS, RJ ;
AREND, WP ;
VERDERBER, E ;
BREWER, MT ;
HANNUM, CH ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :341-346
[8]  
FAKIH H, 1987, FERTIL STERIL, V47, P213
[9]   INTERLEUKIN-1 RECEPTOR BLOCKADE IMPROVES SURVIVAL AND HEMODYNAMIC PERFORMANCE IN ESCHERICHIA-COLI SEPTIC SHOCK, BUT FAILS TO ALTER HOST RESPONSES TO SUBLETHAL ENDOTOXEMIA [J].
FISCHER, E ;
MARANO, MA ;
VANZEE, KJ ;
ROCK, CS ;
HAWES, AS ;
THOMPSON, WA ;
DEFORGE, L ;
KENNEY, JS ;
REMICK, DG ;
BLOEDOW, DC ;
THOMPSON, RC ;
LOWRY, SF ;
MOLDAWER, LL .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (05) :1551-1557
[10]   INTERLEUKIN-1 RECEPTOR ANTAGONIST ACTIVITY OF A HUMAN INTERLEUKIN-1 INHIBITOR [J].
HANNUM, CH ;
WILCOX, CJ ;
AREND, WP ;
JOSLIN, FG ;
DRIPPS, DJ ;
HEIMDAL, PL ;
ARMES, LG ;
SOMMER, A ;
EISENBERG, SP ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :336-340